| Dr Michelle D Brandom, PHARM D | |
|
830 Middle Rd, Bettendorf, IA 52722-4101 | |
| (563) 355-6908 | |
| Not Available |
| Full Name | Dr Michelle D Brandom |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 830 Middle Rd, Bettendorf, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164869467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 21490 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle D Brandom, PHARM D 830 Middle Rd, Bettendorf, IA 52722-4101 Ph: (563) 355-5345 | Dr Michelle D Brandom, PHARM D 830 Middle Rd, Bettendorf, IA 52722-4101 Ph: (563) 355-6908 |
News Archive
Salmonella are highly adaptive bacteria. They can live in the presence and absence of oxygen and thus propagate in the gut. The ingestion by humans occurs mainly via contaminated egg dishes such as mayonnaise or raw milk products as well as meat or sausages. Infections with Salmonella lead to severe diarrhea and fever, particularly in patients harbouring a compromised immune system.
Writing in the International Journal of Nanomedicine, Professor Dongki Yang, from the Department of Physiology, Gachon University, South Korea, has reviewed the available knowledge on the coronaviruses, current approaches to tackle the newly emerged SARS-CoV-2 infection, and the innovative application of nanotechnology in the COVID-19 pandemic.
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
The ventilator, developed by researchers from the Medical Robotics Research Group of the University of Málaga in a record time of 20 days to strengthen health care response to COVID-19, is already being manufactured, after receiving authorization from the Spanish Agency of Medicines and Medical Devices upon fulfilling all requirements for its approval.
› Verified 6 days ago
Mary E Gassman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 858 Middle Rd, Bettendorf, IA 52722 Phone: 563-355-7838 Fax: 563-359-3312 | |
Alice Yinlan Chang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5465 54th Avenue Ct, Bettendorf, IA 52722 Phone: 563-639-5830 | |
Holly Arnold, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2151 Kimberly Rd, Bettendorf, IA 52722 Phone: 563-324-5004 | |
Dr. Daniel Petefish, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4500 Utica Ridge Rd, Bettendorf, IA 52722 Phone: 563-742-2410 | |
Jessica M Coon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3425 Middle Rd, Bettendorf, IA 52722 Phone: 563-332-6049 Fax: 563-332-6162 | |
Marcia Ann Huechteman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 830 Middle Rd, Bettendorf, IA 52722 Phone: 563-355-5345 Fax: 563-355-6908 | |
Lisa Annette Wienclaw, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 830 Middle Rd, Bettendorf, IA 52722 Phone: 563-355-5345 |